Rituximab in the Treatment of Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|243-249

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 243-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3151-3159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcome and Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Japan

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c21-c27

Karger

Access to resources Recommend Favorite

Influenza vaccination and anti‐neutrophil cytoplasmic antibody‐associated vasculitis

By  

NEPHROLOGY, Vol. 20, Iss. 7, 2015-07 ,pp. : 511-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis

By  

Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. : c100-c107

Karger

Access to resources Recommend Favorite

Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1922-1932

John Wiley & Sons Inc

Access to resources Recommend Favorite